G

Galderma Group AG
F:PY30

Watchlist Manager
Galderma Group AG
F:PY30
Watchlist
Price: 33.8 EUR -1.17% Market Closed
Market Cap: €8B

Wall St Price Targets

PY30 Price Targets Summary
Galderma Group AG

Wall Street analysts forecast PY30 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PY30 is 41.5 EUR with a low forecast of 31.32 EUR and a high forecast of 56.16 EUR.

Lowest Forecast
Price Target
31.32 EUR
7% Downside
Average Forecast
Price Target
41.5 EUR
23% Upside
Highest Forecast
Price Target
56.16 EUR
66% Upside
Galderma Group AG Competitors:
Price Targets
LBRT
Liberty Oilfield Services Inc
47% Upside

Revenue
Forecast

11% / Year
Past Growth
13% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
11% / Year
Past Growth
13% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 3 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 8 years is 13%.

Gross Profit
Forecast

11% / Year
Past Growth
15% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
11% / Year
Past Growth
15% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 3 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 8 years is 15%.

Operating Income
Forecast

30% / Year
Past Growth
20% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
30% / Year
Past Growth
20% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 3 years, the compound annual growth rate for Operating Income has been 30%. The projected CAGR for the next 8 years is 20%.

Pre-Tax Income
Forecast

N/A
Past Growth
55% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
55% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Pre-Tax Income over the next 3 years is 55%.

Net Income
Forecast

N/A
Past Growth
28% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
28% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Net Income over the next 8 years is 28%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PY30's stock price target?
Price Target
41.5 EUR

According to Wall Street analysts, the average 1-year price target for PY30 is 41.5 EUR with a low forecast of 31.32 EUR and a high forecast of 56.16 EUR.

What is the Revenue forecast for Galderma Group AG?
Projected CAGR
13%

Over the last 3 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 8 years is 13%.

What is the Gross Profit forecast for Galderma Group AG?
Projected CAGR
15%

Over the last 3 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 8 years is 15%.

What is the Operating Income forecast for Galderma Group AG?
Projected CAGR
20%

Over the last 3 years, the compound annual growth rate for Operating Income has been 30%. The projected CAGR for the next 8 years is 20%.

What is the Pre-Tax Income forecast for Galderma Group AG?
Projected CAGR
55%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 55%.

What is the Net Income forecast for Galderma Group AG?
Projected CAGR
28%

The compound annual growth rate for Net Income over the next 8 years is 28%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett